Vivimed Labs Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul '26 Jul 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	421	438	410	410	547	1,202
Market Cap Growth	2.63%	6.67%	0%	-25.00%	-54.48%	-9.94%
Enterprise Value	4,381	4,268	4,182	3,585	4,190	4,763
Last Close Price	5.08	5.28	4.95	4.95	6.60	14.50
Forward PE	-	3.14	3.14	3.14	3.14	3.14
PS Ratio	0.55	0.57	0.34	0.26	0.29	0.50
PB Ratio	-0.20	-0.21	-1.17	-7.52	1.39	0.33
P/TBV Ratio	-	-	-	-	-	0.58
P/FCF Ratio	6.23	6.48	-	-	1.80	10.80
P/OCF Ratio	5.47	5.68	-	-	1.55	4.37
PEG Ratio	-	0.09	0.09	0.09	0.09	0.09
EV/Sales Ratio	5.74	5.59	3.47	2.25	2.23	2.00
EV/FCF Ratio	64.84	63.18	-	-	13.80	42.79
Debt / Equity Ratio	-1.89	-1.89	-10.70	-69.36	9.67	0.99
Debt / FCF Ratio	58.81	58.81	-	-	12.55	32.24
Net Debt / Equity Ratio	-1.88	-1.88	-10.68	-68.99	9.57	0.97
Net Debt / EBITDA Ratio	-2.71	-2.71	-43.54	-17.23	-2.03	-51.79
Net Debt / FCF Ratio	58.61	58.61	-59.79	-14.47	12.43	31.60
Asset Turnover	0.09	0.09	0.13	0.16	0.17	0.19
Inventory Turnover	2.06	2.06	1.00	1.00	1.71	0.63
Quick Ratio	0.10	0.10	0.18	0.21	0.18	0.25
Current Ratio	0.38	0.38	0.80	0.84	0.80	1.36
Return on Equity (ROE)	-	-	-	-267.64%	-162.76%	-17.00%
Return on Assets (ROA)	-12.85%	-12.85%	-1.93%	-2.69%	-11.34%	-1.23%
Return on Invested Capital (ROIC)	-56.38%	-42.09%	-5.48%	-8.73%	-36.21%	-3.42%
Return on Capital Employed (ROCE)	-56.40%	-56.40%	-5.60%	-7.70%	-35.90%	-2.80%
Earnings Yield	-418.97%	-403.10%	-77.87%	-110.73%	-600.36%	-56.27%
FCF Yield	16.04%	15.43%	-15.31%	-63.42%	55.47%	9.26%
Buyback Yield / Dilution	-0.63%	-0.63%	-	-	-	-
Total Shareholder Return	-0.63%	-0.63%	-	-	-	-